Interobserver variability in the diagnosis of crypt dysplasia in barrett esophagus

American Journal of Surgical Pathology

Volumn 35, Issue 1, 2011, Pages 45-54

  Coco, Dominique P ^a   Goldblum, John R ^b   Hornick, Jason L ^a   Lauwers, Gregory Y ^c   Montgomery, Elizabeth ^d   Srivastava, Amitabh ^e   Wang, Helen ^f   Odze, Robert D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d YJohns Hopkins Hospital   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f Beth Israel Deaconess Medical Center   (Israel)

Author keywords

columnar metaplasia; GERD; intraepithelial neoplasia; pathology

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CARCINOMA IN SITU; ESOPHAGUS; ESOPHAGUS TUMOR; HUMAN; METAPLASIA; MUCOSA; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; METAPLASIA; MUCOUS MEMBRANE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 78650863600     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181ffdd14     Document Type: Article

References (12)

1. Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol. 2003;98:1931-1939.
2. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997;92:212-215.
3. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982-993.
4. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978;70:1-5.
5. Kaye PV, Haider SA, Ilyas M, et al. Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry. Histopathology. 2009;54:699-712.
6. Lomo LC, Blount PL, Sanchez CA, et al. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol. 2006;30:423-435.
7. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368-378.
8. Odze RD. Update on the diagnosis and treatment Barrett's esophagus and related neoplastic precursor lesions. Arch Path Lab Med. 2008;132:1577-1585.
9. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 1988;19: 166-178.
10. Rucker-Schmidt R, Sanchez C, Blount P, et al. Non-adenomatous dysplasia in Barrett's esophagus: a clinical, pathologic and DNA content flow cytometric study. Am J Surg Pathol. 2009;33:886-893.
11. Srivastava A, Coco D, Sanchez CA, et al. Risk of Conventional Dysplasia and Adenocarcinoma in Patients With Barrett's Esophagus and Crypt Dysplasia: a Prospective Follow-Up Study of 214 Patients. Presented at the United States and Canadian Academy of Pathology Annual Meeting, 2010.
12. Zhang X, Huang Q, Goyal RK, et al. DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions. Am J Surg Pathol. 2008;32:1327-1335.